An injectable oleogel‐based bupivacaine formulation for prolonged non‐opioid post‐operative analgesia.
Preclinical Model: Pig Post-Operative Pain Model
Date: July 2024
View Case Study
A Novel Sensory Wave (P25) in Myelin Oligodendrocyte Glycoprotein-induced Experimental Autoimmune Encephalomyelitis Murine Model.
Preclinical Model: MOG-EAE Rodent Model
Date: January 2024
ADS012, a single strain live biotherapeutic product, attenuates tolerance to repeated morphine dosing in mice.
Preclinical Model: Opioid Tolerance Mouse Model
Date: March 2023
DYSPORT®: Intraoperative abobotulinumtoxinA alleviates pain after surgery and improves general wellness in a translational animal model.
Date: December 2022
Chemokine-capturing wound contact layer rescues dermal healing.
Preclinical Model: Diabetic Wound Healing Pig Model
Date: July 2021
ZYNRELEF®: Mechanism of action of HTX-011: a novel, extended- release, dual-acting local anesthetic formulation for postoperative pain.
Date: December 2019
A novel proliposomal ropivacaine oil: pharmacokinetic–pharmacodynamic studies after subcutaneous administration in pigs.
Preclinical Model: Pig Wound Healing Model
Date: May 2016
Enhancing stroke models with diversity: the impact of age, sex, and comorbidities.
Preclinical Model: MCAo and 4VO Rodent Models
Date: January 2025
Enhancing spinal cord injury models with diversity: incorporating age and sex in preclinical research.
Preclinical Model: In Vitro and In Vivo Stroke Models
